Serum in cervical cancer patients (original) (raw)
Clinical value of pretreatment serum Cyfra 21–1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer
Gemma Kenter, K.N. Gaarenstroom
Cancer, 1995
View PDFchevron_right
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study
Olav Vintermyr
American journal of obstetrics and gynecology, 2017
View PDFchevron_right
Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer
Dorota Olszewska-Słonina
Współczesna Onkologia
View PDFchevron_right
A study of serum biomarkers associated with relapse of cervical cancer
louise bohr mordhorst
Anticancer research, 2012
View PDFchevron_right
Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?
Gemma Kenter, K.N. Gaarenstroom
Gynecologic Oncology, 2000
View PDFchevron_right
A Study of Biomarkers in Cervical Carcinoma and Clinical Correlation of the Novel Biomarker MN
Silvia Pastorekova
Gynecologic Oncology, 1996
View PDFchevron_right
Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma
Kenji Hashimoto
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
View PDFchevron_right
Molecular quantification and mapping of lymph-node micrometastases in cervical cancer
John Shepherd
The Lancet, 2001
View PDFchevron_right
Functional biomarkers in cervical precancer: An overview
Radhika Srinivasan
Diagnostic Cytopathology, 2009
View PDFchevron_right
The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
Beata Kotowicz
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015
View PDFchevron_right
Cervical cancer: Biomarkers for diagnosis and treatment
Subramanyam Dasari
Clinica Chimica Acta, 2015
View PDFchevron_right
Decreased cytokeratin 7 expression correlates with the progression of cervical squamous cell carcinoma and poor patient outcomes
Keita Kai
Journal of Obstetrics and Gynaecology Research, 2019
View PDFchevron_right
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy
Petra Stieber
Gynecologic Oncology, 1990
View PDFchevron_right
The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients
Mariusz Bidziński
International Journal of Gynecological Cancer, 2008
View PDFchevron_right
Serum M3/M21 in ovarian cancer patients
Engelbert Hanzal
British journal of cancer, 1997
View PDFchevron_right
Characterization of molecular markers indicative of cervical cancer progression
William Dynan
PROTEOMICS - Clinical Applications, 2009
View PDFchevron_right
Histopathological and immunohistochemical (cytokeratins AE1/AE3) study of the parametrium of patients with early stage cervical cancer
Airo Tsubura
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
View PDFchevron_right
MIB 1 Immunostaining in Cervical Carcinoma of Young Patients
Guendalina Lucarini
Gynecologic Oncology, 1997
View PDFchevron_right
Clinico-morphological parameters affecting survival of patients with advanced cervical cancer
Malgorzata Klimek
2011
View PDFchevron_right
Viral and cellular biomarkers used for improving prevention and management of cervical cancer
ANA-CATALINA SAVU
Practica medicală, 2021
View PDFchevron_right
Feasibility and Diagnostic Accuracy of Ultrastaging in the Detection of Micrometastases in Sentinel and Non-sentinel Lymph Nodes in Cervical Cancer: A Single-Center Retrospective Study With a Five-Year Follow-Up Period
Madalina Balica
Curēus, 2024
View PDFchevron_right
SIGNIFICANCE OF CA 125 AND CEA AS BIOMARKERS IN ASSESSING PROGRESS OF TREATMENT FOR CERVICAL CANCER
Javeed Ahmad, Kaiser Jamil
View PDFchevron_right
Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence
henrique gebrim
International Journal of Gynecology & Obstetrics, 2015
View PDFchevron_right
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)
David Kindelberger
Molecular Cancer Therapeutics, 2020
View PDFchevron_right
Current scenario of biomarkers in cervical cancer and oncogenesis by HPV
Danielle Traesel
Jornal Brasileiro de Doenças Sexualmente Transmissíveis, 2019
View PDFchevron_right
Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: A retrospective case-control surgico-pathological study
Pierangelo Marchiolè
Gynecologic Oncology, 2005
View PDFchevron_right
Association of biomarkers in pre-invasive and invasive cervical carcinoma
Damir Babic
Molecular and experimental biology in medicine, 2019
View PDFchevron_right
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
Stefania Cosio
Biomedicine & Pharmacotherapy, 2004
View PDFchevron_right
The utility of immunocytochemistry in invasive adenocarcinoma of the cervix
JM Cain
American Journal of Obstetrics and Gynecology, 1992
View PDFchevron_right
Cervical Cancer, Version 2.2015
Nelson Teng
Journal of the National Comprehensive Cancer Network, 2015
View PDFchevron_right
Clinical Value of Hematological Biomarkers in Uterine Cervical Cancer
Viorel Scripcariu
Chirurgia, 2016
View PDFchevron_right